|

Reinforced Pancreaticojejunostomy With or Without glubran2

RECRUITINGPhase 2Sponsored by Minia University
Actively Recruiting
PhasePhase 2
SponsorMinia University
Started2025-01-15
Est. completion2026-04-15
Eligibility
Age18 Years – 75 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06756074

Summary

Pancreatic fistula is one of the most serious complication after pancreatoduodenectomy. To reduce pancreatic fistula, many authors recommend different techniques in pancreatojejunostomy. The purpose of this study is to determine which is the best method in preventing pancreatic fistula by enforce pancreaticojejunostomy with tissue glue and to investigate its long term clinical outcomes.

Eligibility

Age: 18 Years – 75 YearsHealthy volunteers accepted
Inclusion Criteria:

* All the patients undergoing pancreaticoduodenectomy for cancer
* Patients able to give their informed consent

Exclusion Criteria:

* Unfit patients for surgery due to severe medical illness.
* Inoperable patients by imaging studies, irresectable tumors after laparotomy or diagnostic laparoscopy.
* Presence of distant metastasis .
* Patients refused to participate in the study.

Conditions5

CancerPancreas CancerPancreatic Ductal AdenocarcinomaPancreatic FistulaPeriampullary Carcinoma

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.